Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


02.07.2018

1 Ann Thorac Surg
1 Arch Pathol Lab Med
2 BMC Cancer
1 Cancer Chemother Pharmacol
1 Cancer Sci
1 Carcinogenesis
4 Clin Cancer Res
5 Clin Lung Cancer
1 Clin Nucl Med
2 Eur Respir J
1 Int J Cancer
1 J Cancer Res Clin Oncol
2 J Clin Oncol
1 J Surg Oncol
5 J Thorac Oncol
1 JAMA Oncol
1 Mol Cancer Ther
1 Nat Med
3 Oncol Rep
1 Oncologist
3 PLoS One
1 Proc Natl Acad Sci U S A
2 Thorax


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Thorac Surg

  1. MULVIHILL MS, Cox ML, Becerra DC, Watson JA, et al
    Higher Utilization of Surgery Confers Superior Survival in Stage I Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2018 Jun 27. pii: S0003-4975(18)30885.
    PubMed     Text format     Abstract available


    Arch Pathol Lab Med

  2. BORCZUK AC
    Keeping Up With Testing Guidelines in Lung Cancer.
    Arch Pathol Lab Med. 2018;142:783-784.
    PubMed     Text format    


    BMC Cancer

  3. WANG Y, Qu X, Kam NW, Wang K, et al
    An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy.
    BMC Cancer. 2018;18:692.
    PubMed     Text format     Abstract available

  4. LI X, Zhou Q, Wang X, Su S, et al
    The effect of low insurance reimbursement on quality of care for non-small cell lung cancer in China: a comprehensive study covering diagnosis, treatment, and outcomes.
    BMC Cancer. 2018;18:683.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  5. HUANG C, Liu S, Tong X, Fan H, et al
    Extracellular vesicles and ctDNA in lung cancer: biomarker sources and therapeutic applications.
    Cancer Chemother Pharmacol. 2018 Jun 8. pii: 10.1007/s00280-018-3586.
    PubMed     Text format     Abstract available


    Cancer Sci

  6. HAYASHI K, Yamamoto N, Karube M, Nakajima M, et al
    Feasibility of carbon-ion radiotherapy for re-irradiation of locoregionally recurrent, metastatic, or secondary lung tumors.
    Cancer Sci. 2018;109:1562-1569.
    PubMed     Text format     Abstract available


    Carcinogenesis

  7. YANG YC, Fu WP, Zhang J, Zhong L, et al
    rs401681 and rs402710 confer lung cancer susceptibility by regulating TERT expression instead of CLPTM1L in East Asian.
    Carcinogenesis. 2018 Jun 23. pii: 5043169. doi: 10.1093.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  8. LI S, Liu S, Deng J, Akbay EA, et al
    Assessing Therapeutic Efficacy of MEK Inhibition in a KRAS G12C-Driven Mouse Model of Lung Cancer.
    Clin Cancer Res. 2018 Jun 26. pii: 1078-0432.CCR-17-3438.
    PubMed     Text format     Abstract available

  9. LAIRD JH, Lok BH, Ma J, Bell A, et al
    Talazoparib is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and Xenografts.
    Clin Cancer Res. 2018 Jun 26. pii: 1078-0432.CCR-18-0401.
    PubMed     Text format     Abstract available

  10. KO EC, Raben D, Formenti SC
    The Integration of Radiotherapy With Immunotherapy for the Treatment of Non-Small Cell Lung Cancer.
    Clin Cancer Res. 2018 Jun 26. pii: 1078-0432.CCR-17-3620.
    PubMed     Text format     Abstract available

  11. LALLO A, Frese KK, Morrow C, Szczepaniak Sloane R, et al
    The combination of the PARP inhibitor olaparib and the Wee1 inhibitor AZD1775 as a new therapeutic option for small cell lung cancer.
    Clin Cancer Res. 2018 Jun 25. pii: 1078-0432.CCR-17-2805.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  12. SU CT, Bhargava A, Shah CD, Halmos B, et al
    Screening Patterns and Mortality Differences in Patients With Lung Cancer at an Urban Underserved Community.
    Clin Lung Cancer. 2018 Jun 5. pii: S1525-7304(18)30139.
    PubMed     Text format     Abstract available

  13. PAOLINI D, Tiseo M, Demma F, Furneri G, et al
    Ventana ALK (D5F3) in the Detection of Patients Affected by Anaplastic Lymphoma Kinase-positive Non-Small-cell Lung Cancer: Clinical and Budget Effect.
    Clin Lung Cancer. 2018 May 31. pii: S1525-7304(18)30132.
    PubMed     Text format     Abstract available

  14. KAWACHI H, Fujimoto D, Morimoto T, Ito M, et al
    Clinical Characteristics and Prognosis of Patients With Advanced Non-Small-cell Lung Cancer Who Are Ineligible for Clinical Trials.
    Clin Lung Cancer. 2018 May 26. pii: S1525-7304(18)30134.
    PubMed     Text format     Abstract available

  15. RAGHAVAN G, Shaverdian N, Chan S, Chu FI, et al
    Comparing Outcomes of Patients With Early-Stage Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy Based on Frailty Status.
    Clin Lung Cancer. 2018 Jun 6. pii: S1525-7304(18)30128.
    PubMed     Text format     Abstract available

  16. LEE A, Howell VM, Itchins M, Wheeler HR, et al
    ROS1-Rearranged Non-Small-Cell Lung Cancer, Factor V Leiden, and Recurrent Venous Thromboses.
    Clin Lung Cancer. 2018 Jun 5. pii: S1525-7304(18)30135.
    PubMed     Text format    


    Clin Nucl Med

  17. PARIHAR AS, Ga A, Sood K, Seam RK, et al
    Incidental Detection of Synchronous Lung Melanoma on 18F-FDG PET/CT in a Patient With Parotid Gland Myoepithelial Carcinoma.
    Clin Nucl Med. 2018 Feb 3. doi: 10.1097/RLU.0000000000001993.
    PubMed     Text format     Abstract available


    Eur Respir J

  18. UGUEN A
    Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times.
    Eur Respir J. 2018;51.
    PubMed     Text format    

  19. LOUBIERE S, Barlesi F, Missy P, Morin F, et al
    Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    Int J Cancer

  20. LEE YM, Kim SJ, Lee JH, Ha E, et al
    Inhaled corticosteroids in COPD and the risk of lung cancer.
    Int J Cancer. 2018 Jun 26. doi: 10.1002/ijc.31632.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  21. PENG Y, Chen Y, Zhang X, Yang Y, et al
    Tumoral cavitation in colorectal cancer patients with unresectable lung metastasis treated with bevacizumab and chemotherapy.
    J Cancer Res Clin Oncol. 2018;144:1339-1346.
    PubMed     Text format     Abstract available


    J Clin Oncol

  22. DONINGTON JS
    Thoracotomy for Stage I Lung Cancer Resections: A Procedure Past Its Time.
    J Clin Oncol. 2018 Jun 26:JCO2018793042. doi: 10.1200/JCO.2018.79.3042.
    PubMed     Text format    

  23. ZWEIG JR, Neal JW
    Infiltrating the Blood-Brain Barrier in ALK-Positive Lung Cancer.
    J Clin Oncol. 2018 Jun 25:JCO2018788554. doi: 10.1200/JCO.2018.78.8554.
    PubMed     Text format    


    J Surg Oncol

  24. KAAKI S, Kidane B, Srinathan S, Tan L, et al
    Is tissue still the issue? Lobectomy for suspicious lung nodules without confirmation of malignancy.
    J Surg Oncol. 2018;117:977-984.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  25. VELCHETI V, Madison R, Ali SM, Schrock AB, et al
    WAC/RET: A Novel RET Oncogenic Fusion Variant in Non-Small Cell Lung Carcinoma.
    J Thorac Oncol. 2018;13:e122-e123.
    PubMed     Text format    

  26. LIN JJ, Zhu VW, Schoenfeld AJ, Yeap BY, et al
    Brigatinib in Patients with Alectinib-Refractory ALK-Positive Non-Small Cell Lung Cancer: A Retrospective Study.
    J Thorac Oncol. 2018 Jun 20. pii: S1556-0864(18)30714.
    PubMed     Text format     Abstract available

  27. NAVARRO A, Martinez-Marti A, Felip E
    HIV-Positive Patients with Lung Cancer: Is Immunotherapy a Safe and Active Option for Them?
    J Thorac Oncol. 2018;13:874-876.
    PubMed     Text format    

  28. ASSALLUM H, Harris K
    The Impact of the Eighth TNM Classification for Lung Cancer on the Endobronchial Ultrasound Procedure.
    J Thorac Oncol. 2018;13:e119-e120.
    PubMed     Text format    

  29. SHIUE K, Cerra-Franco A, Shapiro R, Estabrook N, et al
    Histology, tumor volume, and radiation dose predict outcomes in non-small cell lung cancer patients after stereotactic ablative radiotherapy.
    J Thorac Oncol. 2018 Jun 26. pii: S1556-0864(18)30716.
    PubMed     Text format     Abstract available


    JAMA Oncol

  30. GANDARA DR, Riess JW, Lara PN Jr
    In Search of an Oncogene Driver for Squamous Lung Cancer.
    JAMA Oncol. 2018 Jun 14. pii: 2684629. doi: 10.1001/jamaoncol.2018.0774.
    PubMed     Text format    


    Mol Cancer Ther

  31. SHIN DH, Jo JY, Han JY
    Dual targeting of ErbB2/ErbB3 for treatment of SLC3A2-NRG1-mediated lung cancer.
    Mol Cancer Ther. 2018 Jun 29. pii: 1535-7163.MCT-17-1178.
    PubMed     Text format     Abstract available


    Nat Med

  32. GUO X, Zhang Y, Zheng L, Zheng C, et al
    Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing.
    Nat Med. 2018 Jun 25. pii: 10.1038/s41591-018-0045.
    PubMed     Text format     Abstract available


    Oncol Rep

  33. PARK WH
    Hydrogen peroxide inhibits the growth of lung cancer cells via the induction of cell death and G1phase arrest.
    Oncol Rep. 2018 Jun 28. doi: 10.3892/or.2018.6535.
    PubMed     Text format     Abstract available

  34. GU Y, Zhang M
    Upregulation of the Kank1 gene inhibits human lung cancer progression in vitro and in vivo.
    Oncol Rep. 2018 Jun 26. doi: 10.3892/or.2018.6526.
    PubMed     Text format     Abstract available

  35. CUI E, Guo H, Shen M, Yu H, et al
    Adiponectin inhibits migration and invasion by reversing epithelialmesenchymal transition in nonsmall cell lung carcinoma.
    Oncol Rep. 2018 Jun 25. doi: 10.3892/or.2018.6523.
    PubMed     Text format     Abstract available


    Oncologist

  36. TOI Y, Sugawara S, Kawashima Y, Aiba T, et al
    Association of Immune-Related Adverse Events with Clinical Benefit in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab.
    Oncologist. 2018 Jun 22. pii: theoncologist.2017-0384.
    PubMed     Text format     Abstract available


    PLoS One

  37. FERRARINI A, Forcato C, Buson G, Tononi P, et al
    A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products.
    PLoS One. 2018;13:e0193689.
    PubMed     Text format     Abstract available

  38. PLAGNOL V, Woodhouse S, Howarth K, Lensing S, et al
    Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling.
    PLoS One. 2018;13:e0193802.
    PubMed     Text format     Abstract available

  39. YANG M, Feng Y, Yue C, Xu B, et al
    Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma.
    PLoS One. 2018;13:e0193428.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  40. YAO K, Peng C, Zhang Y, Zykova TA, et al
    RSK2 phosphorylates T-bet to attenuate colon cancer metastasis and growth.
    Proc Natl Acad Sci U S A. 2017 Nov 13. pii: 201710756.
    PubMed     Text format     Abstract available


    Thorax

  41. FIELD JK, Duffy SW
    Lung cancer CT screening: are we ready to consider screening biennially in a subgroup of low-risk individuals?
    Thorax. 2018 Jun 28. pii: thoraxjnl-2018-211814.
    PubMed     Text format    

  42. KENNEDY MPT, Cheyne L, Darby M, Plant P, et al
    Lung cancer stage-shift following a symptom awareness campaign.
    Thorax. 2018 Jun 27. pii: thoraxjnl-2018-211842.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: